【结 构 式】 |
【药物名称】Cizolirtine citrate, E-3710 citrate, E-4018, E-4961((S)-isomer), E-4960((R)-isomer) 【化学名称】(±)-O-[2-(Dimethylamino)ethyl]-1-methyl-alpha-phenyl-1H-pyrazol-5-methanol citrate 【CA登记号】142155-44-0, 251375-82-3 ((1:1) salt), 148981-63-9 ((R)-isomer), 148981-65-1 ((S)-isomer), 142155-43-9 (free base), 148981-64-0 【 分 子 式 】C21H29N3O8 【 分 子 量 】451.48058 |
【开发单位】Esteve (Originator) 【药理作用】ANALGESIC AND ANESTHETIC DRUGS, Analgesic Drugs, Antipyretics, Non-Opioid Analgesics, RENAL-UROLOGIC DRUGS, Urinary Incontinence Therapy |
合成路线1
The key compound 5-(alpha-hydroxybenzyl)-1-methyl-1H-pyrazole [(±)-I] was obtained by two related ways: 1) by condensation of N-methylpyrazole with benzonitrile and butyl lithium in tetrahydrofuran and reduction of the obtained ketone with sodium borohydride in methanol or 2) by condensation of N-methylpyrazole with benzaldehyde and butyl lithium in THF/toluene. The alkylation of [(±)-I] with 2-(dimethylamino)ethyl chloride hydrochloride was carried out using phase transfer conditions and reaction with citric acid using propanone as solvent.
【1】 Farré, A.J.; Frigola, J.; Cizolirtine Citrate. Drugs Fut 2002, 27, 8, 721. |
【2】 Colombo, A.; Pares, J.; Frigola, J. (Laboratorios del Dr. Esteve, SA); Aryl-heteroaryl-carbinol derivs. having an analgesic activity. EP 0289380; FR 2613720; JP 1988267761; US 5017596 . |
合成路线2
The optical resolution of (±)-cizolirtine was accomplished by recrystallizing diastereoisomeric salts formed with the antipodes of di-p-toluoyltartaric acid in isopropanol.
【1】 Farré, A.J.; Frigola, J.; Cizolirtine Citrate. Drugs Fut 2002, 27, 8, 721. |
【2】 Frigola-Constansa, J.; Torrens-Jover, A. (Laboratorios del Dr. Esteve, SA); Resolution of amines. EP 1024137; ES 2130079; US 6187930; WO 9902500 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
54584 | N,N-dimethyl-2-[(1-methyl-1H-pyrazol-5-yl)(phenyl)methoxy]-1-ethanamine; N,N-dimethyl-N-{2-[(1-methyl-1H-pyrazol-5-yl)(phenyl)methoxy]ethyl}amine | C15H21N3O | 详情 | 详情 | ||
54585 | N,N-dimethyl-2-{[(R)-(1-methyl-1H-pyrazol-5-yl)(phenyl)methyl]oxy}-1-ethanamine; N,N-dimethyl-N-(2-{[(R)-(1-methyl-1H-pyrazol-5-yl)(phenyl)methyl]oxy}ethyl)amine | C15H21N3O | 详情 | 详情 | ||
54586 | N,N-dimethyl-2-{[(S)-(1-methyl-1H-pyrazol-5-yl)(phenyl)methyl]oxy}-1-ethanamine; N,N-dimethyl-N-(2-{[(S)-(1-methyl-1H-pyrazol-5-yl)(phenyl)methyl]oxy}ethyl)amine | C15H21N3O | 详情 | 详情 |
合成路线3
Resolution of alcohol [(±)-I] as its diastereomeric O-acetylmandelate esters and saponification of each of them in ethanol in the presence of catalytic amounts of sodium cyanide yielded the enantiomerically pure alcohols [(R)-(+)-I] and [(S)-()-I].
【1】 Hueso, J.; Frigola, J.; Farré, A.; Berrocal, J.; Gutierrez, B.; Preparation of the enantiomers of the analgesic E-3710. Bioorg Med Chem Lett 1993, 3, 2, 269. |
【2】 Farré, A.J.; Frigola, J.; Cizolirtine Citrate. Drugs Fut 2002, 27, 8, 721. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(rac)-(I) | 54583 | (1-methyl-1H-pyrazol-5-yl)(phenyl)methanol; 5-(alpha-hydroxybenzyl)-1-methyl-1H-pyrazole | C11H12N2O | 详情 | 详情 | |
(R)-(+)-(I) | 54587 | (R)-(1-methyl-1H-pyrazol-5-yl)(phenyl)methanol | C11H12N2O | 详情 | 详情 | |
(S)-(-)-(I) | 54588 | (S)-(1-methyl-1H-pyrazol-5-yl)(phenyl)methanol | C11H12N2O | 详情 | 详情 |
合成路线4
The transesterification of [(±)-I] with vinyl acetate enzymatically catalyzed (lipase) allowed the selective recovery of the enatiomer [(R)-(+)-I] and the hydrolysis and racemization of the undesired enantiomer [(S)-()-II] with hydrochloric acid.
【1】 Farré, A.J.; Frigola, J.; Cizolirtine Citrate. Drugs Fut 2002, 27, 8, 721. |
【2】 Frigola Constansa, J.; Cuberes Altisent, M.R.; Berrocal Romero, J.M.; Gotor Santamaria, V. (Laboratorios del Dr. Esteve, SA); Method for separating carbinols. ES 2128959; FR 2742147; US 5849931; WO 9720817 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(rac)-(I) | 54583 | (1-methyl-1H-pyrazol-5-yl)(phenyl)methanol; 5-(alpha-hydroxybenzyl)-1-methyl-1H-pyrazole | C11H12N2O | 详情 | 详情 | |
(R)-(+)-(I) | 54587 | (R)-(1-methyl-1H-pyrazol-5-yl)(phenyl)methanol | C11H12N2O | 详情 | 详情 | |
(S)-(-)-(III) | 54589 | (S)-(1-methyl-1H-pyrazol-5-yl)(phenyl)methyl acetate | C13H14N2O2 | 详情 | 详情 |
合成路线5
Asymmetric reduction of ketone (III) with catecholborane or boranemethyl sulfide complex and CBS-oxazaborolidene as catalyst afforded [(R)-(+)-I] or [(S)-()-I].
【1】 Farré, A.J.; Frigola, J.; Cizolirtine Citrate. Drugs Fut 2002, 27, 8, 721. |
【2】 Frigola-Constansa, J.; Torrens-Jover, A. (Laboratorios del Dr. Esteve, SA); Process for obtaining enantiomers of cizolirtine. EP 1029852; ES 2130083; US 6118009; WO 9907684 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
20631 | (R)-Methyl oxazaborolidine; (3aR)-1-methyl-3,3-diphenyltetrahydro-3H-pyrrolo[1,2-c][1,3,2]oxazaborole | 112022-83-0 | C18H20BNO | 详情 | 详情 | |
(R)-(+)-(I) | 54587 | (R)-(1-methyl-1H-pyrazol-5-yl)(phenyl)methanol | C11H12N2O | 详情 | 详情 | |
(III) | 54590 | (1-methyl-1H-pyrazol-5-yl)(phenyl)methanone | C11H10N2O | 详情 | 详情 |
合成路线6
Ethyl (R)-mandelate [(R)-IV] was protected as its tert-butyldimethylsilyl ether and reduced with DIBAL to [(R)-V], which was treated with ethoxycarbonylmethyl-enetriphenylphosphorane, followed by reduction to give [(R)-VI]. Subsequent oxidation to [(R)-VII] and cyclization by reaction with methylhydrazine afforded a mixture of pyrazolines [(R)-VIII]. Oxidation to pyrazole and deprotection yielded [(R)-(+)-I].
【1】 Farré, A.J.; Frigola, J.; Cizolirtine Citrate. Drugs Fut 2002, 27, 8, 721. |
【2】 Hueso, J.; Frigola, J.; Farré, A.; Berrocal, J.; Gutierrez, B.; Preparation of the enantiomers of the analgesic E-3710. Bioorg Med Chem Lett 1993, 3, 2, 269. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(R)-(+)-(I) | 54587 | (R)-(1-methyl-1H-pyrazol-5-yl)(phenyl)methanol | C11H12N2O | 详情 | 详情 | |
(R)-(IV) | 54591 | ethyl (2R)-2-hydroxy-2-phenylethanoate | C10H12O3 | 详情 | 详情 | |
(R)-(V) | 54592 | (2R)-2-{[tert-butyl(dimethyl)silyl]oxy}-2-phenylethanal | C14H22O2Si | 详情 | 详情 | |
(R)-(VI) | 54593 | (E,4S)-4-{[tert-butyl(dimethyl)silyl]oxy}-4-phenyl-2-buten-1-ol | C16H26O2Si | 详情 | 详情 | |
(R)-(VII) | 54594 | (E,4S)-4-{[tert-butyl(dimethyl)silyl]oxy}-4-phenyl-2-butenal | C16H24O2Si | 详情 | 详情 | |
(R)-(VIII) | 54595 | tert-butyl(dimethyl)silyl (R)-(1-methyl-4,5-dihydro-1H-pyrazol-5-yl)(phenyl)methyl ether; 5-[(R)-{[tert-butyl(dimethyl)silyl]oxy}(phenyl)methyl]-1-methyl-4,5-dihydro-1H-pyrazole | C17H28N2OSi | 详情 | 详情 |